Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - bisoprolol fumarate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - levetiracetam -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - clopidogrel hydrogen sulfate; clopidogrel (as hydrogen sulfate) -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - montelukast sodium -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: mannitol; titanium dioxide; diacetylated monoglycerides; crospovidone; hypromellose phthalate; light magnesium oxide; ethylcellulose; hyprolose; magnesium stearate; purified talc; heavy magnesium oxide - indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: ethylcellulose; titanium dioxide; mannitol; crospovidone; magnesium stearate; iron oxide yellow; diacetylated monoglycerides; heavy magnesium oxide; light magnesium oxide; purified talc; hyprolose; hypromellose phthalate - indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - candesartan cilexetil -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - candesartan cilexetil -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - pioglitazone hydrochloride -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - risedronate sodium hemipentahydrate -